|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online 21 June 2006
doi: 10.1242/dev.02477
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

1 Institut für Biochemie, Universität Erlangen, Fahrstrasse 17,
D-91054 Erlangen, Germany
2 Max-Planck-Institut für Neurobiologie, Martinsried, Germany.
Author for correspondence (e-mail:
m.wegner{at}biochem.uni-erlangen.de)
Accepted 1 June 2006
| SUMMARY |
|---|
|
|
|---|
Key words: Sry, High-mobility-group, Redundancy, Glia, Oligodendrocyte, Neural crest
| INTRODUCTION |
|---|
|
|
|---|
In the past, we have studied the role of Sox10 during mouse embryonic
development. Sox10 is strongly expressed in the neural crest where it is
turned on shortly before neural crest cells start to migrate from the dorsal
aspect of the neural tube (Kuhlbrodt et
al., 1998
; Southard-Smith et
al., 1998
). Sox10 is not only expressed in neural crest stem
cells, but also in several neural crest derivatives where its presence is
either transient or lasts through terminal differentiation into the mature
state (Britsch et al., 2001
;
Southard-Smith et al., 1998
).
In accordance with its expression pattern, Sox10 has functions in neural crest
stem cells where it is needed for maintenance of pluripotency and survival,
and in peripheral glia, melanocytes and enteric neural crest, where it
regulates specification and differentiation events
(Britsch et al., 2001
;
Kim et al., 2003
).
Sox10 gene defects lead to several neurocristopathies in mouse, man
and zebrafish (Britsch et al.,
2001
; Dutton et al.,
2001
; Herbarth et al.,
1998
; Kapur, 1999
;
Pingault et al., 1998
;
Southard-Smith et al., 1998
).
These present as partial pigmentation abnormalities, colonic aganglionosis and
in some instances as peripheral neuropathies in the heterozygous state. In
homozygotes, melanocytes, peripheral glia and the enteric nervous system are
entirely missing.
Outside the neural crest and its derivatives, Sox10 is found in the central
nervous system (Kuhlbrodt et al.,
1998
) where it is restricted to the oligodendrocyte lineage.
Oligodendrocyte development is affected by Sox10 gene defects at the
stage of terminal differentiation and myelination, although Sox10 is already
expressed in these cells from the time of their specification
(Inoue et al., 2004
;
Stolt et al., 2002
).
Sox10 is expressed in an overlapping manner with both Sox9 and Sox8
(Cheung et al., 2005
;
Maka et al., 2005
;
Stolt et al., 2004
;
Stolt et al., 2003
), and
phenotypes are primarily observed at developmental stages where Sox10 exhibits
singular or significantly higher expression than Sox9 or Sox8 in a particular
cell type. For oligodendrocytes, this is the stage of terminal
differentiation. At this point, Sox9 expression is extinguished and among the
remaining SoxE proteins, Sox10 is expressed at a higher level than Sox8
(Stolt et al., 2004
).
Similarly, the enteric nervous system defect in Sox10-deficient mice arises in
the vagal neural crest (Kapur,
1999
), which predominantly expresses Sox10, no Sox9 and only low
levels of Sox8 (Maka et al.,
2005
). In compound mutants, Sox10-dependent defects in the enteric
nervous system and in oligodendrocyte differentiation are aggravated by
additional loss of Sox8 (Maka et al.,
2005
; Stolt et al.,
2004
). These results are again compatible with functional
equivalence among SoxE proteins and expression levels deciding whether
functional redundancy among co-expressed SoxE proteins is partial or
complete.
To study functional equivalence among SoxE proteins, we have generated a mouse in which we have replaced Sox10 by Sox8. This mouse expresses Sox8 in all tissues where Sox10 is normally expressed, and in amounts that closely correspond to normal levels of Sox10 expression. Nevertheless, we find that Sox8 is not able to completely rescue the phenotype of Sox10-deficient mice. Instead, the level of phenotypic rescue varies between cell types from none to complete with no obvious correlation to Sox10 expression levels in the respective cell types. From these new data, we conclude that functional equivalence among SoxE proteins is only partial and that each SoxE protein has unique functions not shared by its relatives.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Gene targeting, generation and genotyping of mouse mutants
The linearized construct was electroporated into E14.1 ES cells which were
then selected with G418 (400 µg per ml) and gancyclovir (2 µM). Selected
ES cell clones were screened by Southern blotting with a 0.6 kb 5'
probe, which recognized a 6.6 kb fragment in case of the wild-type allele and
a 6.0 kb fragment in case of the targeted allele in genomic DNA digested with
NcoI (Fig. 1A,B).
Appropriate integration of the 3' end of the targeting construct was
verified using a 0.6 kb 3' probe on ES cell DNA digested with
BamHI and ScaI. This probe hybridized to a 5.4 kb fragment
in the targeted allele as opposed to a 4.6 kb fragment in the wild-type allele
(Fig. 1A,B). Two targeted ES
cell lines were injected into C57Bl/6J blastocysts to generate chimeras.
Chimeric males from two independent clones transmitted the targeted allele to
their offspring. No differences were detected between mice derived from the
two different ES cell lines. To remove the neomycin resistance cassette,
heterozygous mutant mice were crossed with EIIa-Cre mice
(Lakso et al., 1996
).
Homozygous mutant embryos were generated by heterozygote intercrosses. The
final Sox10Sox8ki allele was sequenced to ensure that
nucleotide changes had not accumulated in the Sox8-coding sequence.
Genotyping was routinely performed on DNA from tail tips, or in case of embryos from yolk sacs, by PCR analysis using a common upper primer located 81 bp upstream of the start codon (5'-CAGGTGGGCGTTGGGCTCTT-3') and two lower primers located 487 bp (5'-TCCCAGGCTAGCCCTAGTG-3') and 651 bp (5'-GCCCAGTTCAGTACCAGAGG-3') downstream of the start codon in Sox10 and Sox8, respectively. A 568 bp fragment was indicative of the wild-type allele, a 732 bp fragment of the targeted allele (Fig. 1E). Deletion of the neomycin resistance cassette was verified by PCR using primers located upstream (5'-AGCCATACCACATTTGTAGAGC-3') and downstream (5'-CTAGATGCTGGCATAGGCGAT-3') of the cassette. A 0.5 kb fragment was indicative of successful Cre-mediated deletion (Fig. 1D).
|
The cDNA (1 µl) was amplified by polymerase chain reaction on a Roche Lightcycler according to the manufacturer's instructions using the LightCycler-FastStart DNA Master SYBR Green kit with the following primer pairs: primers A and B (5'-TCAGTCTCGGCTGTCCAGCC-3' and 5'-GAAGAGCCCAACGCCACCT-3') are located on exons II and III of Sox10 and recognize transcripts from the wild-type and the mutant locus (Fig. 1A); primers C and D (5'-GTCAGATGGGAACCCAGAGCAC-3' and 5'-CCCGTAGCCAGCTGCCGAG-3') are located on exons IV and V of Sox10 and recognize transcripts from the wild-type locus only (Fig. 1A); primers 5'-CCTGGGCATGGAGTCCTG-3' and 5'-GGAGCAATGATCTTGATCTTC-3' amplify ß-actin transcripts; primers 5'-GTTCGTGTACTGCGGCAAGA-3' and 5'-ACAGGATTCATGGCCACACC-3' amplify rpl8 transcripts that were both used for normalization. For ß-actin primers and primer pair A/B an annealing temperature of 60°C was used, 64°C for the others.
Brains from 18.5 dpc embryos were used to prepare nuclear extracts
(Sock et al., 1996
). Samples
were loaded onto denaturing 10% SDS-polyacrylamide gels and blotted onto
nitrocellulose membranes (Sock et al.,
1996
). Polyclonal antisera directed against group E Sox proteins
(1:3000 dilution) (Kuhlbrodt et al.,
1998
) or Sox8 (1:5000 dilution)
(Stolt et al., 2005
) and a
monoclonal directed against RNA polymerase II (1:3000 dilution; Active Motif)
served as primary antibodies, horseradish peroxidase-coupled protein A or goat
anti-mouse antibody as secondary detection reagent in western blots using the
ECL detection system (Sock et al.,
1996
).
Tissue preparation, immunohistochemistry and in situ hybridization
Embryos were isolated at 10.5 dpc to 18.5 dpc from staged pregnancies.
After fixation in 4% paraformaldehyde, specimens were either dehydrated,
bleached and rehydrated for whole-mount studies or cryoprotected by overnight
incubation at 4°C in 30% sucrose, embedded in OCT compound at -80°C
and sectioned at 10 µm or at 20 µm
(Stolt et al., 2004
;
Stolt et al., 2003
).
Immunohistochemistry was performed on 10 µm sections or on dissected
gastrointestinal tracts. The following primary antibodies were used in various
combinations: anti-Sox10 guinea pig antiserum (1:2000 dilution)
(Stolt et al., 2004
),
anti-Sox8 guinea pig antiserum (1:1000 dilution)
(Stolt et al., 2005
),
anti-Brn3.0 rabbit antiserum (1:100 dilution)
(Fedtsova and Turner, 1995
),
anti-Oct6 rabbit antiserum (1:2000 dilution)
(Sock et al., 1996
),
anti-Krox20 rabbit antiserum (1:500 dilution)
(Sock et al., 1997
),
anti-PGP9.5 rabbit antiserum (1:400; Biotrend), anti-Phox2b rabbit antiserum
(1:2000 dilution, gift of C. Goridis, Ecole Normale Superieure, Paris),
anti-Olig2 rabbit antiserum (1:2000 dilution, gift of H. Takebayashi, Kyoto
University), anti-B-FABP rabbit antiserum, (1:10,000 dilution, gift of C.
Birchmeier and T. Müller, MDC, Berlin), anti-NF165 mouse monoclonal
(1:200 dilution, Developmental Studies Hybridoma Bank), anti-NeuN mouse
monoclonal (1:500 dilution, Chemicon), anti-MBP mouse monoclonal (1:500
dilution, Chemicon) and anti-MPZ mouse monoclonal (1:10000 dilution; gift of
J. J. Archelos, Graz). Secondary antibodies conjugated to Cy2 and Cy3
immunofluorescent dyes (Dianova) were used for detection. Dissected
gastrointestinal tracts were also used for NADPH diaphorase staining
(Scherer-Singler et al.,
1983
).
In situ hybridization was performed on 20 µm sections with DIG-labelled
antisense riboprobes for MBP and PLP or on whole embryos with probes for Kit,
Mitf and Dct (Britsch et al.,
2001
; Stolt et al.,
2002
). All steps except probe hybridization and final colorimetric
detection were performed automatically on a Biolane HTI (Hölle &
Hüttner AG).
Samples were analyzed and documented either with a Leica (Bensheim, Germany) inverted microscope (DMIRB) equipped with a cooled MicroMax CCD camera (Princeton Instruments, Trenton, NJ), a Leica TCS SL confocal microscope or with a Leica MZFLIII stereomicroscope equipped with an Axiocam (Zeiss, Oberkochem, Germany).
| RESULTS |
|---|
|
|
|---|
ES cell clones carrying these alterations at the Sox10 locus were obtained by standard gene targeting techniques and injected into blastocysts (Fig. 1B). Chimeric mice from two independent ES cell clones transmitted the genetic alteration to their progeny (Fig. 1C,E). The neo cassette was deleted through Cre recombinase activity (Fig. 1D). Progeny from both ES cell clones had identical phenotypes. The resulting allele was sequenced to confirm that no mutations had occurred in the Sox8-coding sequences. It is henceforth referred to as Sox10Sox8ki or Sox8 replacement allele.
All possible genotypes were obtained in the expected Mendelian ratios when
mice heterozygous for the Sox8 replacement allele
(Sox10+/Sox8ki) were crossed with each other and genotyping was
performed on embryos. This was similarly observed for early embryonic stages
(10.5-12.5 dpc) and for embryos between 14.5 and 18.5 dpc
(Fig. 2A). No increased
embryonic lethality occurred in Sox10Sox8ki/Sox8ki mice around 13.5
dpc, as previously observed for mice with inactive Sox10
(Sox10Dom/Dom) (Britsch et al.,
2001
; Herbarth et al.,
1998
; Southard-Smith et al.,
1998
). Sox10Sox8ki/Sox8ki mice also survived birth, in
contrast to Sox10-deficient mice. Thus, Sox8 is able to rescue both the
partial embryonic and the perinatal lethality of Sox10-deficient mice.
However, Sox10Sox8ki/Sox8ki mice failed to thrive, were severely growth retarded and invariably died during the first postnatal week so that no Sox10Sox8ki/Sox8ki mice were detected by genotyping at the time of weaning (data not shown). This already indicated that the phenotypic rescue was not complete.
To ensure that the incomplete phenotypic rescue was not due to reduced expression of the Sox8 replacement allele, total RNA was isolated from wild-type embryos and Sox10Sox8ki/Sox8ki littermates at either 10.5 dpc or 12.5 dpc. After reverse transcription, expression levels from wild-type allele and Sox8 replacement allele were compared by quantitative RT-PCR with primers matching sequences in the 5'-UTR (primers A and B in Fig. 1A). The 5'-UTRs of transcripts for wild-type and replacement allele are identical so that the primers functioned equally well on both transcripts. At the same time the primers failed to detect the transcripts from the native Sox8 gene. By quantitative RT-PCR, expression levels for the Sox8 replacement allele were indistinguishable from the wild-type Sox10 allele (Fig. 2B).
This approach only allowed us to compare expression levels of wild-type and Sox8 replacement allele at early times of development for whole embryos. To study expression levels of both alleles in single tissues at later stages, we quantified overall expression from the Sox10 locus in tissues from Sox10+/Sox8ki embryos at 13.5 dpc and 18.5 dpc with the already mentioned primers A and B, as well as expression of the wild-type allele with primers C and D (Fig. 1A). By comparing the obtained values to the ones for wild-type tissues, we were able to determine the contribution of the wild-type allele to overall expression from the Sox10 locus in Sox10+/Sox8ki tissues as 40% to 59% (Fig. 2C). Considering the precision limits of the quantitative RT-PCR, wild-type and Sox8 replacement allele were thus expressed at approximately equal levels in the analyzed Sox10+/Sox8ki tissues. As there is furthermore no reason to assume that the wild-type allele should be expressed at different levels in Sox10+/Sox8ki and Sox10+/+ tissues, we conclude that the Sox8 replacement allele is expressed at wild-type levels. Using nuclear extracts, we also compared protein levels in brains of 18.5-dpc old wild-type and Sox10Sox8ki/Sox8ki embryos. Relative molecular masses of Sox10 and Sox8 are so similar that both appear in a single band on western blots. Compared with wild-type brains, the combined amounts of Sox8 and Sox10 were unchanged in Sox10Sox8ki/Sox8ki brains, as evident from Western blots with anti-SoxE antibodies (Fig. 2D). At the same time, Sox8 levels were significantly increased in Sox10Sox8ki/Sox8ki brains, as assessed by Sox8-specific antibodies. In the central nervous system at least, the joint amount of Sox8 and Sox10 protein was thus not significantly altered upon replacement of Sox10 by Sox8 in our mouse model.
|
Analysis of the cranial and vagal neural crest derivatives in Sox10Sox8ki mice
Loss of Sox10 leads to severe defects in the cranial and vagal neural crest
(Britsch et al., 2001
;
Herbarth et al., 1998
;
Southard-Smith et al., 1998
).
In Sox10Dom/Dom mice, for example, cranial ganglia of predominantly
neural crest origin are severely reduced, whereas those with significant
placodal contributions are less affected
(Herbarth et al., 1998
). When
cranial ganglia were analyzed by EGFP autofluorescence in
Sox10Sox8ki/Sox8ki embryos at 10.5 dpc and compared with
Sox10+/Sox8ki littermates, no obvious alterations were detected.
All cranial ganglia were present in their regular shape
(Fig. 3A,B,D,E). In particular,
we did not observe the size reductions in the dorsal portions of the
trigeminal and facial ganglia nor the thinning of the proximal
glossopharyngeal and vagus parts, which are typical of Sox10-deficient mice
(Herbarth et al., 1998
).
Whereas ß-galactosidase staining in cranial ganglia of
Sox10lacZ/lacZ embryos is strongly reduced relative to otic vesicle
staining when compared with Sox10+/lacZ littermates
(Britsch et al., 2001
), no such
differences were observed for the EGFP signal between
Sox10Sox8ki/Sox8ki and Sox10+/Sox8ki embryos. By
contrast, EGFP autofluorescence in the Sox10Sox8ki/Sox8ki embryos
was uniformly increased throughout all expressing tissues when compared with
Sox10+/Sox8ki littermates owing to higher EGFP expression from two
instead of one allele (Fig.
3A,B,D,E). Age-matched wild-type embryos did not exhibit specific
fluorescence (Fig. 3C,F). At
least at this level of resolution, development of cranial ganglia is therefore
normal in Sox10Sox8ki/Sox8ki mice.
Thus, we turned to the analysis of the enteric nervous system as the main
derivative of the vagal neural crest. Sox10-deficient embryos lack an enteric
nervous system throughout the whole gastrointestinal tract, including stomach
and oesophagus (Britsch et al.,
2001
; Herbarth et al.,
1998
; Kapur, 1999
;
Southard-Smith et al., 1998
).
Severe defects in the enteric nervous system were also detected in
Sox10Sox8ki/Sox8ki embryos. At the end of embryogenesis, both small
and large intestine were devoid of immunoreactivity for PGP9.5, a ubiquitin
hydrolase expressed by all enteric neurons and neuronal precursors, and NADPH
diaphorase staining, which specifically labels NOS-positive neurons
(Fig. 4A,B). Similarly, there
was no B-FABP immunoreactivity, which is specific for enteric glia (data not
shown). EGFP autofluorescence confirmed that, fore- and hindgut were never
colonized by enteric neural crest cells. Apoptotic cells were strongly
increased in the area where vagal neural crest cells are normally found prior
to gut colonization (data not shown). Oesophagus and stomach of
Sox10Sox8ki/Sox8ki mice, by contrast, possessed normal looking
enteric ganglia and plexus (Fig.
4A,B). In Sox10-deficient mice, these two areas also lack an
enteric nervous system (Britsch et al.,
2001
; Southard-Smith et al.,
1998
). Although restricted to the anteriormost parts of the
gastrointestinal tract, there is thus a certain degree of phenotypic rescue in
Sox10Sox8ki/Sox8ki mice.
|
|
Analysis of melanocyte development in Sox10Sox8ki mice
Melanocyte development is also extremely sensitive to loss of Sox10
(Britsch et al., 2001
;
Southard-Smith et al., 1998
).
Thus, it may not be surprising that melanocyte development was severely
disturbed in Sox10Sox8ki/Sox8ki mice. Sox10Sox8ki/Sox8ki
mice have a completely white coat (Fig.
5A). Melanin was absent from all hair follicles and hair shafts,
as evident from whole skin preparations, indicating that melanocytes were
absent or unable to produce melanin (Fig.
5B). To distinguish between these possibilities, we performed
whole-mount in situ hybridization on 12.5 dpc embryos using several markers
for early melanoblasts. With dopachrome tautomerase (Dct) as a marker,
melanoblasts were not detected (Fig.
5C). Similarly, very few residual melanoblasts were spotted in
Sox10Sox8ki/Sox8ki mice with a probe against the
melanocyte-specific transcription factor Mitf. As both Dct and Mitf are direct
target genes of Sox10 (Jiao et al.,
2004
; Ludwig et al.,
2004a
; Potterf et al.,
2001
), Kit was employed as a third marker. Although Kit
additionally labels other cells than melanocytes such as mast cells, we
observed a greater than 90% reduction of Kit positive cells in
Sox10Sox8ki/Sox8ki mice (Fig.
5C). There is thus virtually no difference in the severity of the
melanocyte defect compared with Sox10LacZ/LacZ mice
(Britsch et al., 2001
), arguing
that Sox8 is unable to compensate for loss of Sox10 in the melanocyte
lineage.
|
Sox10-deficient embryos at this age also have thinned and defasciculated
peripheral nerves that lack all Schwann cells
(Britsch et al., 2001
;
Herbarth et al., 1998
;
Sonnenberg-Riethmacher et al.,
2001
; Southard-Smith et al.,
1998
). When peripheral nerves of Sox10Sox8ki/Sox8ki
were stained with neurofilament 165 (NF-165), no obvious thinning was
observed. Instead neurofilament staining resembled that of wild-type nerves
(Fig. 7A,B). Additionally,
cells were present along the peripheral nerves of
Sox10Sox8ki/Sox8ki embryos that exhibited EGFP autofluorescence
and, by morphology and position, probably correspond to the Schwann cells
that, in the wild type, instead possessed nuclear Sox10 staining
(Fig. 7G-J). At this stage,
many Schwann cells in the wild type had entered the promyelinating stage
marked by expression of the transcription factors Oct6 and Krox20
(Bermingham et al., 1996
;
Jaegle et al., 1996
;
Topilko et al., 1994
;
Zorick et al., 1996
).
Immunohistochemical analysis of Sox10Sox8ki/Sox8ki embryos with
these markers not only confirmed the Schwann cell identity of the cells
detected along the peripheral nerves, but also proved that these cells had
progressed normally through lineage development into the promyelinating stage
(Fig. 7C-F). Normal development
of myelinating Schwann cells was further confirmed when peripheral nerves were
studied at postnatal day 3. At this age, sheath-like structures in the nerve
had formed and started to accumulate significant amounts of the myelin basic
protein (MBP) and the myelin protein zero (MPZ), indicating the onset of
myelination (Fig. 7K-N). Again,
no difference could be detected with any of the markers between the wild-type
and Sox10Sox8ki/Sox8ki mice, arguing that Schwann cell development
proceeds on schedule when Sox10 is replaced by Sox8. The normal development of
dorsal root ganglia and peripheral nerves also explains why
Sox10Sox8ki/Sox8ki mice survive birth and are able to breathe, in
contrast to Sox10LacZ/LacZ mice.
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
|
To validate our mouse model, we had to ensure that Sox8 is expressed in Sox10Sox8ki/Sox8ki embryos in the same spatiotemporal pattern and in identical amounts as Sox10 in the wild type. To achieve this goal, we removed the complete open reading frame of Sox10 and embedded the Sox8 open reading frame in such a way into the Sox10 locus that gene regulatory elements, transcriptional start site, 5' non-coding exons and translational start site were all left untouched. The major difference between the wild-type Sox10 locus and the replacement allele is that the Sox8 open reading frame is present on a single exon, whereas the Sox10 open reading frame in the wild type is split between three exons. The Sox8 replacement allele is nevertheless transcribed as an intron-containing message that is spliced prior to translation.
We checked expression levels of the Sox8 replacement allele and compared it with the wild type. There was no significant difference in transcript levels between the wild-type and the Sox8 replacement allele, both at the level of the complete Sox10Sox8ki/Sox8ki embryo at early times of development and in several tissues of Sox10+/Sox8ki embryos at later times. Importantly, expression of wild-type and the Sox8 replacement allele was also comparable in those tissues in which there was no complete rescue by the Sox8 replacement allele, including the melanocyte containing skin, the gut and the CNS. Additionally, the amount of Sox8 protein in the brain of Sox10Sox8ki/Sox8ki was very similar to the combined amounts of Sox8 and Sox10 protein in the wild type. Although we might have missed differences in expression levels in a minor population of normally Sox10-expressing cells, the most likely conclusion from our study is that overall amounts for SoxE transcripts and proteins are not significantly altered in our mouse mutant. Therefore, we believe that the Sox10Sox8ki/Sox8ki mouse is indeed a suitable model with which to study the functional equivalence of Sox8 and Sox10.
The limited phenotypic rescue of the Sox10 deficiency in the
Sox10Sox8ki/Sox8ki mouse was unexpected and the two SoxE proteins
are far less exchangeable than predicted from previous studies on Sox8/Sox10
compound mutants (Maka et al.,
2005
; Stolt et al.,
2004
). The phenotypic rescue furthermore varied strongly between
tissues, so that it was nearly complete in the peripheral nervous system,
limited in enteric nervous system and oligodendrocytes, and non-existent in
the melanocyte lineage. Interestingly, the effectiveness with which Sox8 was
able to rescue did not correlate with its natural occurrence in the tissue or
cell type. Thus, there was strong rescue in the peripheral nervous system, but
none in melanocytes, although neither tissue expresses Sox8 endogenously.
Severe developmental defects were furthermore observed in the developing
enteric nervous system and in differentiating oligodendrocytes of
Sox10Sox8ki/Sox8ki mice, despite the naturally occurring
co-expression of Sox8 and Sox10 in these tissues.
Recent overexpression studies had pointed to significant functional
redundancy between closely related Sox proteins
(Bylund et al., 2003
;
Cheung and Briscoe, 2003
;
Graham et al., 2003
;
Taylor and LaBonne, 2005
;
Zhang et al., 2005
). Studies
on SoxE proteins had indicated that all three SoxE proteins function alike
during early neural crest development by expanding the neural crest at the
expense of the neural tube (Cheung and
Briscoe, 2003
; Taylor and
LaBonne, 2005
). These studies do not necessarily contradict our
results, as early neural crest development (apart from the vagal neural crest)
was also fairly normal in our Sox10Sox8ki/Sox8ki mice (data not
shown). In our mouse model, functional differences between the two SoxE
proteins became obvious at later developmental processes which are easier to
study in gene replacement studies than in conventional electroporation or
microinjection studies. Similar observations were also made in the Phox2
replacements (Coppola et al.,
2005
).
Our gene replacement approach also guarantees a tight control on
spatiotemporal expression. In chick electroporation or Xenopus
microinjection experiments, overexpressed proteins are usually difficult to
control in their expression levels and equally difficult to confine regionally
and temporally. High expression levels, in turn, may mask functional
differences that exist between Sox proteins at lower physiological
concentrations. Furthermore, overexpression studies on SoxE proteins were
performed in wild-type embryos that still possessed all three SoxE genes.
Thus, overexpression of one SoxE protein could have led to increased
expression of the other ones, making it difficult to attribute effects solely
to the overexpressed Sox protein. At least in the case of Sox9, ectopic
expression has been reported to induce endogenous Sox10 expression
(Cheung and Briscoe, 2003
).
Our results require a reinterpretation of previously obtained data.
Although there is no doubt, that Sox8 contributes to enteric nervous system
development and oligodendrocyte differentiation at times when Sox10 is very
important for these processes (Maka et
al., 2005
; Stolt et al.,
2004
), it appears unlikely now that the different contributions of
Sox8 and Sox10 to these developmental processes can solely be attributed to
their different level of expression. As evident from our analysis of enteric
nervous system development and oligodendrocyte differentiation in
Sox10Sox8ki/Sox8ki mice, there have to be functions that are unique
to Sox10 and cannot be taken over by Sox8. The spatiotemporal regulation of
endothelin receptor-B expression by Sox10 in enteric neural crest precursors
may be such a case, as Sox8 apparently failed to compensate the loss of Sox10
(Zhu et al., 2004
). The
reciprocal existence of unique functions for Sox8 appears likely, but has not
formally been proven in our experiments. If existent, however, they must be
non-essential, as both enteric nervous system development and oligodendrocyte
differentiation are eventually completed in Sox8-deficient mice
(Sock et al., 2001
).
At present, it is unclear what exactly these unique functions are. Nor is
it clear what the structural basis for these functional differences is.
Biochemical studies have so far failed to reveal dramatic differences in DNA
binding activity or transactivation potential among SoxE proteins
(Schepers et al., 2003
;
Stolt et al., 2004
) indicating
that the differences may be subtle or temporary. It is tempting to speculate
that the functional differences are mediated by the non-conserved regions,
which in the case of Sox10 are the first 60 amino acids and regions from its
central part. Additionally, at least part of the functional differences
between SoxE proteins might be based on differential patterns of
posttranslational modifications. These would have largely escaped previous
analyses, as these modifications are usually unstable and not faithfully
preserved in biochemical experiments unless special precautions are taken.
Examples for such differences in posttranslational modifications are indeed
emerging. It has been shown recently, that Sox9 and Sox10 proteins are
sumoylated (Girard and Goossens,
2006
; Taylor and LaBonne,
2005
). Whereas the C-terminal sumoylation sites are conserved in
Sox8, the N-terminal site, corresponding to lysine 55 in Sox10 is not. The
sumoylation site that is not conserved between Sox10 and Sox8 could therefore
uniquely influence Sox10 activity. Additionally, two phosphorylation sites for
protein kinase A with clear functional importance are present in Sox9, but
absent from Sox8 and Sox10 (Huang et al.,
2000
). It will be important to determine the various
post-translational modifications in the future and see how they affect and
diversify the function of the three SoxE proteins.
| ACKNOWLEDGMENTS |
|---|
| Footnotes |
|---|
| REFERENCES |
|---|
|
|
|---|
Acampora, D., Avantaggiato, V., Tuorto, F., Barone, P., Perera, M., Choo, D., Wu, D., Corte, G. and Simeone, A. (1999). Differential transcriptional control as the major molecular event in generating Otx1-/- and Otx2-/- divergent phenotypes. Development 126,1417 -1426.[Abstract]
Aoki, Y., Saint-Germain, N., Gyda, M., Magner-Fink, E., Lee, Y. H., Credidio, C. and Saint-Jeannet, J. P. (2003). Sox10 regulates the development of neural crest-derived melanocytes in Xenopus. Dev. Biol. 259,19 -33.[CrossRef][Medline]
Bermingham, J. R., Scherer, S. S., O'Connell, S., Arroyo, E.,
Kalla, K. A., Powell, F. L. and Rosenfeld, M. G. (1996).
Tst-1/Oct-6/SCIP regulates a unique step in peripheral myelination and is
required for normal respiration. Genes Dev.
10,1751
-1762.
Bouchard, M., Pfeffer, P. and Busslinger, M. (2000). Functional equivalence of the transcription factors Pax2 and Pax5 in mouse development. Development 127,3703 -3713.[Abstract]
Bowles, J., Schepers, G. and Koopman, P. (2000). Phylogeny of the SOX family of developmental transcription factors based on sequence and structural indicators. Dev. Biol. 227,239 -255.[CrossRef][Medline]
Britsch, S., Goerich, D. E., Riethmacher, D., Peirano, R. I.,
Rossner, M., Nave, K. A., Birchmeier, C. and Wegner, M.
(2001). The transcription factor Sox10 is a key regulator of
peripheral glial development. Genes Dev.
15, 66-78.
Bylund, M., Andersson, E., Novitch, B. G. and Muhr, J. (2003). Vertebrate neurogenesis is counteracted by Sox1-3 activity. Nat. Neurosci. 6,1162 -1168.[CrossRef][Medline]
Chaboissier, M.-C., Kobayashi, A., Vidal, V. I. P.,
Lützkendorf, S., van de Kant, H. J. G., Wegner, M., de Rooij, D. G.,
Behringer, R. R. and Schedl, A. (2004). Functional analysis
of Sox8 and Sox9 during sex determination in the mouse.
Development 131,1891
-1901.
Cheung, M. and Briscoe, J. (2003). Neural crest
development is regulated by the transcription factor Sox9.
Development 130,5681
-5693.
Cheung, M., Chaboissier, M.-C., Mynett, A., Hirst, E., Schedl, A. and Briscoe, J. (2005). The transcriptional control of trunk neural crest induction, survival, and delamination. Dev. Cell 8,179 -192.[CrossRef][Medline]
Chiang, E. F., Pai, C. I., Wyatt, M., Yan, Y. L., Postlethwait, J. and Chung, B. (2001). Two sox9 genes on duplicated zebrafish chromosomes: expression of similar transcription activators in distinct sites. Dev. Biol. 231,149 -163.[CrossRef][Medline]
Coppola, E., Pattyn, A., Guthrie, S. C., Goridis, C. and Studer, M. (2005). Reciprocal gene replacements reveal unique functions for Phox2 genes during neural differentiation. EMBO J. 24,4392 -4403.[CrossRef][Medline]
Dutton, K. A., Pauliny, A., Lopes, S. S., Elworthy, S., Carney,
T. J., Rauch, J., Geisler, R., Haffter, P. and Kelsh, R. N.
(2001). Zebrafish colourless encodes sox10 and specifies
non-ectomesenchymal neural crest fates. Development
128,4113
-4125.
Fedtsova, N. and Turner, E. E. (1995). Brn-3.0 expression identifies early postmitotic CNS neurons and sensory neural precursors. Mech. Dev. 53,291 -304.[CrossRef][Medline]
Friedrich, R., Schlierf, B., Tamm, E. R., Bösl, M. R. and
Wegner, M. (2005). The class III POU domain protein Brn-1 can
fully replace the related Oct-6 during Schwann cell development and
myelination. Mol. Cell. Biol.
25,1821
-1829.
Girard, M. and Goossens, M. (2006). Sumoylation of the SOX10 transcription factor regulates its transcriptional activity. FEBS Lett. 580,1635 -1641.[CrossRef][Medline]
Graham, V., Khudyakov, J., Ellis, P. and Pevny, L. (2003). SOX2 functions to maintain neural progenitor identity. Neuron 39,749 -765.[CrossRef][Medline]
Hanks, M., Wurst, W., Anson-Cartwright, L., Auerbach, A. B. and
Joyner, A. L. (1995). Rescue of the En-1 mutant phenotype by
replacement of En-1 with En-2. Science
269,679
-682.
Herbarth, B., Pingault, V., Bondurand, N., Kuhlbrodt, K.,
Hermans-Borgmeyer, I., Puliti, A., Lemort, N., Goossens, M. and Wegner, M.
(1998). Mutation of the Sry-related Sox10 gene in Dominant
megacolon, a mouse model for human Hirschsprung disease. Proc.
Natl. Acad. Sci. USA 95,5161
-5165.
Huang, W., Zhou, X., Lefebvre, V. and de Crombrugghe, B.
(2000). Phosphorylation of SOX9 by cyclic AMP-dependent protein
kinase A enhances SOX9's ability to transactivate a Col2a1
chondrocyte-specific enhancer. Mol. Cell. Biol.
20,4149
-4158.
Inoue, K., Khajavi, M., Ohyama, T., Hirabayashi, S.-I., Wilson, J., Reggin, J. D., Mancias, P., Butler, I. J., Wilkinson, M. F., Wegner, M. et al. (2004). Molecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutations. Nat. Genet. 36,361 -369.[CrossRef][Medline]
Jaegle, M., Mandemakers, W., Broos, L., Zwart, R., Karis, A., Visser, P., Grosveld, F. and Meijer, D. (1996). The POU factor Oct-6 and Schwann cell differentiation. Science 273,507 -510.[Abstract]
Jiao, Z., Mollaaghababa, R., Pavan, W. J., Antonellis, A., Green, E. D. and Hornyak, T. J. (2004). Direct interaction of Sox10 with the promoter of murine Dopachrome Tautomerase (Dct) and synergistic activation of Dct expression with Mitf. Pigment Cell Res. 17,352 -362.[CrossRef][Medline]
Kapur, R. P. (1999). Early death of neural crest cells is responsible for total enteric aganglionosis in Sox10(Dom)/Sox10(Dom) mouse embryos. Pediatr. Dev. Pathol. 2,559 -569.[CrossRef][Medline]
Kim, J., Lo, L., Dormand, E. and Anderson, D. J. (2003). SOX10 maintains multipotency and inhibits neuronal differentiation of neural crest stem cells. Neuron 38, 17-31.[CrossRef][Medline]
Kuhlbrodt, K., Herbarth, B., Sock, E., Hermans-Borgmeyer, I. and
Wegner, M. (1998). Sox10, a novel transcriptional modulator
in glial cells. J. Neurosci.
18,237
-250.
Lakso, M., Pichel, J. G., Gorman, J. R., Sauer, B., Okamoto, Y.,
Lee, E., Alt, F. W. and Westphal, H. (1996). Efficient in
vivo manipulation of mouse genomic sequences at the zygote stage.
Proc. Natl. Acad. Sci. USA
93,5860
-5865.
Ludwig, A., Rehberg, S. and Wegner, M. (2004a). Melanocyte-specific expression of dopachrome tautomerase is dependent on synergistic gene activation by the Sox10 and Mitf transcription factors. FEBS Lett. 556,236 -244.[CrossRef][Medline]
Ludwig, A., Schlierf, B., Schardt, A., Nave, K. A. and Wegner, M. (2004b). A Sox10 rtTA mouse line for tetracycline-inducible expression of transgenes in neural crest cells and oligodendrocytes. Genesis 40,171 -175.[CrossRef][Medline]
Maka, M., Stolt, C. C. and Wegner, M. (2005). Identification of Sox8 as a modifier gene in a mouse model of Hirschsprung disease reveals underlying molecular defect. Dev. Biol. 277,155 -169.[CrossRef][Medline]
Pingault, V., Bondurand, N., Kuhlbrodt, K., Goerich, D. E., Prehu, M.-O., Puliti, A., Herbarth, B., Hermans-Borgmeyer, I., Legius, E., Matthijs, G. et al. (1998). Sox10 mutations in patients with Waardenburg-Hirschsprung disease. Nat. Genet. 18,171 -173.[CrossRef][Medline]
Potterf, S. B., Mollaaghababa, R., Hou, L., Southard-Smith, E. M., Hornyak, T. J., Arnheiter, H. and Pavan, W. J. (2001). Analysis of SOX10 function in neural crest-derived melanocyte development: SOX10-dependent transcriptional control of dopachrome tautomerase. Dev. Biol. 237,245 -257.[CrossRef][Medline]
Schepers, G., Wilson, M., Wilhelm, D. and Koopman, P.
(2003). Sox8 is expressed during testis differentiation in mice
and synergizes with SF1 to activate the AMH promoter in vitro. J.
Biol. Chem. 278,28101
-28108.
Scherer-Singler, U., Vincent, S. R., Kimura, H. and McGeer, E. G. (1983). Demonstration of a unique population of neurons with NADPH-diaphorase histochemistry. J. Neurosci. Methods 9,229 -234.[CrossRef][Medline]
Sock, E., Enderich, J., Rosenfeld, M. G. and Wegner, M.
(1996). Identification of the nuclear localization signal of the
POU domain protein Tst-1/Oct6. J. Biol. Chem.
271,17512
-17518.
Sock, E., Leger, H., Kuhlbrodt, K., Schreiber, J., Enderich, J., Richter-Landsberg, C. and Wegner, M. (1997). Expression of Krox proteins during differentiation of the O2-A progenitor cell line CG-4. J. Neurochem. 68,1911 -1919.[Medline]
Sock, E., Schmidt, K., Hermanns-Borgmeyer, I., Bösl, M. R.
and Wegner, M. (2001). Idiopathic weight reduction in mice
deficient in the high-mobility-group transcription factor Sox8.
Mol. Cell. Biol. 21,6951
-6959.
Sonnenberg-Riethmacher, E., Miehe, M., Stolt, C. C., Goerich, D. E., Wegner, M. and Riethmacher, D. (2001). Development and degeneration of dorsal root ganglia in the absence of the HMG-domain transcription factor Sox10. Mech. Dev. 109,253 -265.[CrossRef][Medline]
Southard-Smith, E. M., Kos, L. and Pavan, W. J. (1998). Sox10 mutation disrupts neural crest development in Dom Hirschsprung mouse model. Nat. Genet. 18, 60-64.[CrossRef][Medline]
Stolt, C. C., Rehberg, S., Ader, M., Lommes, P., Riethmacher,
D., Schachner, M., Bartsch, U. and Wegner, M. (2002).
Terminal differentiation of myelin-forming oligodendrocytes depends on the
transcription factor Sox10. Genes Dev.
16,165
-170.
Stolt, C. C., Lommes, P., Sock, E., Chaboissier, M.-C., Schedl,
A. and Wegner, M. (2003). The Sox9 transcription factor
determines glial fate choice in the developing spinal cord. Genes
Dev. 17,1677
-1689.
Stolt, C. C., Lommes, P., Friedrich, R. P. and Wegner, M.
(2004). Transcription factors Sox8 and Sox10 perform
non-equivalent roles during oligodendrocyte development despite functional
redundancy. Development
131,2349
-2358.
Stolt, C. C., Schmitt, S., Lommes, P., Sock, E. and Wegner, M. (2005). Impact of transcription factor Sox8 on oligodendrocyte specification in the mouse embryonic spinal cord. Dev. Biol. 281,323 -331.
Takada, S. and Koopman, P. (2003). Origin and possible roles of the SOX8 transcription factor gene during sexual development. Cytogenet. Genome Res. 101,212 -218.[CrossRef][Medline]
Taylor, K. M. and LaBonne, C. (2005). SoxE factors function equivalently during neural crest and inner ear development and their activity is regulated by SUMOylation. Dev. Cell 9,593 -603.[CrossRef][Medline]
Topilko, P., Schneider, M. S., Levi, G., Baron, V. E. A., Chennoufi, A. B., Seitanidou, T., Babinet, C. and Charnay, P. (1994). Krox-20 controls myelination in the peripheral nervous system. Nature 371,796 -799.[CrossRef][Medline]
Tybulewicz, V. L., Crawford, C. E., Jackson, P. K., Bronson, R. T. and Mulligan, R. C. (1991). Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 65,1153 -1163.[CrossRef][Medline]
Wegner, M. (1999). From head to toes: the
multiple facets of Sox proteins. Nucleic Acids Res.
27,1409
-1420.
Wegner, M. and Stolt, C. C. (2005). From stem cells to neurons and glia: a soxist's view of neural development. Trends Neurosci. 28,583 -588.[CrossRef][Medline]
Zhang, C., Basta, T. and Klymkowsky, M. W. (2005). Sox7 and Sox18 are essential for cardiogenesis in Xenopus. Dev. Dyn. 234,878 -891.[CrossRef][Medline]
Zhu, L., Lee, H.-O., Jordan, C. R. S., Cantrell, V. A., Southard-Smith, E. M. and Shin, M. K. (2004). Spatiotemporal regulation of endothelin receptor-B by Sox10 in neural crest-derived enteric neuron precursors. Nat. Genet. 36,732 -737.[CrossRef][Medline]
Zorick, T. S., Syroid, D. E., Arroyo, E., Scherer, S. S. and Lemke, G. (1996). The transcription factors SCIP and Krox-20 mark distinct stages and cell fates in Schwann cell differentiation. Mol. Cell. Neurosci. 8,129 -145.[CrossRef][Medline]
This article has been cited by other articles:
![]() |
S. I. E. Guth, K. Schmidt, A. Hess, and M. Wegner Adult-onset degeneration of adipose tissue in mice deficient for the Sox8 transcription factor J. Lipid Res., July 1, 2009; 50(7): 1269 - 1280. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hoser, M. R. Potzner, J. M. C. Koch, M. R. Bosl, M. Wegner, and E. Sock Sox12 Deletion in the Mouse Reveals Nonreciprocal Redundancy with the Related Sox4 and Sox11 Transcription Factors Mol. Cell. Biol., August 1, 2008; 28(15): 4675 - 4687. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Reiprich, C. C. Stolt, S. Schreiner, R. Parlato, and M. Wegner SoxE Proteins Are Differentially Required in Mouse Adrenal Gland Development Mol. Biol. Cell, April 1, 2008; 19(4): 1575 - 1586. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Werner, A. Hammer, M. Wahlbuhl, M. R. Bosl, and M. Wegner Multiple conserved regulatory elements with overlapping functions determine Sox10 expression in mouse embryogenesis Nucleic Acids Res., October 8, 2007; 35(19): 6526 - 6538. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Schreiner, F. Cossais, K. Fischer, S. Scholz, M. R. Bosl, B. Holtmann, M. Sendtner, and M. Wegner Hypomorphic Sox10 alleles reveal novel protein functions and unravel developmental differences in glial lineages Development, September 15, 2007; 134(18): 3271 - 3281. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. O'Donnell, C.-S. Hong, X. Huang, R. J. Delnicki, and J.-P. Saint-Jeannet Functional analysis of Sox8 during neural crest development in Xenopus Development, October 1, 2006; 133(19): 3817 - 3826. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||